Return to Article Details
EVALUATION OF SERUM VISFATIN AS A NOVEL BIOMARKER IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS CORRELATION WITH LIVER ENZYMES
Download
Download PDF